Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion type Assertion NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_head.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion description "[By performing systematic biochemical and bioinformatical analyses, we identified two miR-221 targets, HECTD2 and RAB1A, which could mediate the development of CRPC phenotype in multiple prostate cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_provenance.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion evidence source_evidence_literature NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_provenance.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion SIO_000772 23770851 NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_provenance.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion wasDerivedFrom befree-20150227 NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_provenance.
- NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_assertion wasGeneratedBy ECO_0000203 NP662601.RAujbp8DZ8bxefODK3N-VXnlU_S0nJ75Ht4nBiA9TsBa0130_provenance.